Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists

The New York Times – Business:

Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.

Gina Kolata
Author: Gina Kolata

This post first appeared in The New York Times – Business. Read the original article.

Written by

Gina Kolata

in

Cholesterol, Clinical Trials, Drugs (Pharmaceuticals), Heart, Krumholz, Harlan M, Maron, David J, Novartis AG, Stroke
←Greaves becomes first woman to win match on European Tour
Lindsay Clancy Trial: Illinois Mom Allegedly Killed 2-Year-Old Son Hours After Texting About Case→

More posts

  • The Papers: ‘I’d rejoin the Army to fight Russia’ and ‘Boiling point’

  • Ex-ESPN Personality Bonnie-Jill Laflin’s Animal Rescue Suspended Over Missing Animal Records

  • Elon Musk says record spending on US midterms was ‘pretty foolish’

  • Hila Klein Says She Can’t Look at Estranged Husband Ethan in New Video Statement

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube